Cesarian Section
6
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (6)
Transplacental Neonatal Transfer of Lidocaine During Urgent Caesarean Delivery
Stratafix vs. PDS (Fascial Closure RCT)
Effects of Music on Post-Cesarean Pain, Anxiety, Breastfeeding and Mother Infant Attachment Impact
Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section
Modes of Delivery Impact Maternal Oxidative Stress Biomarkers and Dynamic Thiol Disulphide Homeostasis
Prediction of Spinal Anesthesia-Induced Hypotension in Cesarian Section: Carotid Artery-Corrected Flow Time Versus Cardiometry